Novartis AG (NVS)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$155.04

Buy

$155.08

arrow-up$2.35 (+1.54%)

Prices updated at 01 Apr 2026, 15:54 EDT

Prices minimum 15 mins delay

Prices in USD

Novartis AG is a part of the healthcare industry. Its main activity is to research and develop healthcare products and pharmaceuticals such as oncology medicines, generic and biosimilar medicines and eye care devices.

S&P 500

0.97%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - General

Chairman

Mr. Simon E Moroney, D.Phil.

CEO

Dr. Vasant Narasimhan

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

75,267

Head office

Lichtstrasse 35

Basel

Switzerland

4056

+41 613241111

investor.relations@novartis.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Frans Van Van Houten, M.Sc. Independent Director	0.20m
Ms. Bridgette P. Heller Independent Director	0.22m
Mr. John Douglas Young Independent Director	0.21m
Dr. Giovanni Caforio, M.D. Chairman of the Board	1.46m
Ms. Ana de Pro Gonzalo Independent Director	0.20m
Mr. Patrice Bula Lead Independent Director	0.21m
Ms. Elizabeth Doherty Independent Director	0.23m
Mr. Harry Kirsch Chief Financial Officer	1.15m
Dr. Nancy C. Andrews, M.D.,PhD Independent Director	0.18m
Mr. Ton Buechner Independent Director	0.18m
Dr. Vasant Narasimhan Chief Executive Officer	1.90m
Dr. Steffen Lang, PhD President, Operations	-
Dr. Shreeram Aradhye, M.D. President, Development and Chief Medical Officer	-
Mr. Carulla Victor Bulto President, US	0.86m
Mr. Simon E Moroney, D.Phil. Vice Chairman of the Board	0.23m
Ms. Karen L. Hale Chief Legal and Compliance Officer	-
Mr. Robert Kowalski Chief People and Organization Officer	-
Mr. Daniel Hochstrasser Independent Director	0.20m
Dr. Aharon Gal, PhD Chief Strategy and Growth Officer	-
Dr. Fiona H. Marshall, PhD President, Biomedical Research	-
Dr. Patrick Horber, M.D. President, International	1.03m
Ms. Elizabeth McNally, M.D.,PhD Director	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Dodge & Cox	9,014,641
Dimensional Fund Advisors, Inc.	8,524,394
Morgan Stanley - Brokerage Accounts	7,728,873
PRIMECAP Management Company	7,579,274
Fisher Asset Management, LLC	7,465,850

Director dealings

Date chevron-l-regular chevron-r-regular	Action
No data

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.